CAMBRIDGE NUTRITIONAL SCIENCES PLC

Board/Management Information • Jul 10, 2025

National Storage Mechanism | Additional information

RNS Number : 4485Q

Cambridge Nutritional Sciences PLC

10 July 2025

Cambridge Nutritional Sciences plc

(the 'Company' or 'CNS')

Directorate Change

CNSL (AIM:CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, is pleased to announce that it has appointed Ajay Patel to the Board as Chief Financial Officer ("CFO") and Executive Director with immediate effect.

Ajay has over 30 year's experience in finance, having graduated from University College London, trained at PWC, and spending 14 years at Tesco in a range of senior finance roles. He has significant CFO and Company secretary exposure to growing businesses in retail, e-commerce, logistics, wholesaling, education and charities. 

Carolyn Rand, Chair, said:  "As a Board, I am delighted to welcome someone with Ajay's experience into our business to work alongside our CEO to help drive the business forward and deliver our strategy.  This is evidence of our commitment to strengthening our Board with individuals who bring a wealth of experience and strategic insight into the organisation. I am sure, together with James we have a very strong Executive team who will play a key part in our future success".

James Cooper, Chief Executive Officer, said:  "I am very pleased to welcome Ajay to our Board and look forward to working closely with him to achieve our strategic objectives.  Ajay has significant experience and I am very excited at how this can help drive our growth agenda as well as develop our people and leadership in the organisation."

Contacts: 

Cambridge Nutritional Sciences Plc	www.cnsplc.com
James Cooper, Chief Executive Officer	investors@cnsplc.com
Cavendish Capital Markets Limited	Tel: 020 7220 0500
Geoff Nash / Edward Whiley (Corporate Finance)
Nigel Birks / Harriet Ward (ECM)

About Cambridge Nutritional Sciences Plc

Cambridge Nutritional Sciences Plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies: 

Ajay Patel, aged 60, does not currently hold any ordinary shares in the Company. Ajay also holds no options in the Company.

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

Current Directorships and Partnerships	Previous Directorships and Partnerships (held in the past five years)
A Tunnel Wood Limited	Entoria Winecellars Limited
	TBP Realisations Limited
	Tengo (Holdings) Limited
	M & G Presents Limited
	Tengo Limited
	TBP Realisations Group Limited
	Sonderwell Bidco Limited
	Better Healthcare Services Limited
	Enviva Care Limited
	Invent Health Limited
	Enviva Complex Care Limited
	Libertatem Healthcare Group Limited
	Sonderwell Midco Limited
	Sonderwell Finco Limited
	BECC: Bespoke Complex Care Support Limited
	Arrow Support Limited
	Diversity Care Solutions Limited
	Libertatem Healthcare Holdings Ltd
	Sonderwell Topco limited
	Sekforde Drinks Limited
	Great Western Wine Company Limited (The)
	Coe of Ilford Limited
	Gin Foundry Limited
	Winecellars Limited
	Entoria Winecellars Limited
	Entoria Group Limited
	Entoria Holdings Limited

TBP Realisations Limited (formerly The Book People Limited) appointed administrators on 16 December 2019. PWC were appointed originally to affect an accelerated M&A process with parallel contingency planning, but no buyer was secured. The final administrator's progress report reported that secured creditor Endless LLP had received £11.10 million while unsecured creditors received 3.69% totalling £541,000.00.

Tengo (Holdings) Limited, M & G Presents Limited, Tengo Limited and TBP Realisations Group Limited all entered Creditors Voluntary Liquidation on 13 March 2020. No realisations were made from the liquidations.

Squeaky Gate entered Creditor's Voluntary Liquidation on 14 April 2014. Non-preferential unsecured creditors claimed £319,373.1. No dividend was declared to these unsecured creditors.

Save for the disclosures above, there are no further disclosures to be made in accordance with Rule 17 and Schedule 2(g) of the AIM Rules.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

BOAUPUQPMUPAPUB